Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Amplia MRI" CRT -D SureScan" Recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure Due to During internal testing conducted as part of next...

Date: December 9, 2016
Company: Medtronic Inc., Cardiac Rhythm and Heart Failure
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Medtronic Inc., Cardiac Rhythm and Heart Failure directly.

Affected Products

Amplia MRI" CRT -D SureScan", Amplia MRI" Quad CRT -D SureScan", Claria MRI" CRT -D SureScan", Claria MRI" Quad CRT -D SureScan. implantable medical devices that automatically detect and treat episodes of ventricular fibrillation, ventricular tachycardia, fast ventricular tachycardia, and bradyarrhythmia.

Quantity: 21,111 ( 13,198 US; 7,913 OUS).

Why Was This Recalled?

During internal testing conducted as part of next generation product development, it was discovered that the AdaptivCRT (aCRT) feature of Amplia MRI and Claria MRI CRT -D devices may appear to be enabled when it is not active.

Where Was This Sold?

This product was distributed to 1 state: DC

Affected (1 state)Not affected

About Medtronic Inc., Cardiac Rhythm and Heart Failure

Medtronic Inc., Cardiac Rhythm and Heart Failure has 9 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report